Development status of dropless cataract surgery
10.3980/j.issn.1672-5123.2022.11.07
- VernacularTitle:无滴眼液的白内障手术发展现状
- Author:
Dong HAN
1
,
2
;
Jing WANG
1
,
2
;
Zhen-Bo ZHAO
1
,
2
;
Kai-Li TANG
1
,
2
;
Yu-Xi DING
1
,
2
;
Si-Qi GAO
1
,
2
;
Jin-Song ZHANG
1
,
2
Author Information
1. Shenyang Aier Excellence Eye Hospital
2. Aier Eye Institute of Cataract and Intraocular Lens, Shenyang 110000, Liaoning Province, China
- Publication Type:Journal Article
- Keywords:
cataract surgery;
endophthalmitis;
drug release system;
anterior chamber injection;
antibiotic prophylaxis infection
- From:
International Eye Science
2022;22(11):1800-1803
- CountryChina
- Language:Chinese
-
Abstract:
As cataract surgery has entered the era of minimally invasive and accurate refractive surgery, higher requirements for perioperative infection control are needed. In recent years, “dropless cataract surgery” has been proposed and is gradually applied in clinical practice. It is based on the combination of different local injection forms in cataract surgery, in which antibiotics and steroids are applied to the operative eye through immediate or sustained release, so that patients do not need to use eye drops throughout the perioperative period.It can not only achieve the purpose of anti-inflammation and anti-infection after surgery, but also reduce the burden of patients, patients' family members and doctors.This article reviews the concept of “dropless cataract surgery”, the combined treatment methods, including combined anterior chamber antibiotic injection, triamcinolone acetonide and moxifloxacin hydrochloride(TriMoxi)and triamcinolone -moxifloxacin and vancomycin(TriMoxiVanc)intravitreal injection, combined dexamethasone lacrimal puncture implantation, continuous or sustained release drug delivery mechanism, as well as its efficacy and safety, with a view to provide a new idea and direction for the prevention of postoperative cataract infection.
